EA201791312A1 - Способы мечения библиотек, кодируемых днк - Google Patents
Способы мечения библиотек, кодируемых днкInfo
- Publication number
- EA201791312A1 EA201791312A1 EA201791312A EA201791312A EA201791312A1 EA 201791312 A1 EA201791312 A1 EA 201791312A1 EA 201791312 A EA201791312 A EA 201791312A EA 201791312 A EA201791312 A EA 201791312A EA 201791312 A1 EA201791312 A1 EA 201791312A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- swording
- dna coded
- coded libraries
- libraries
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1068—Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/08—Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support
- C40B50/10—Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support involving encoding steps
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098037P | 2014-12-30 | 2014-12-30 | |
| PCT/US2015/067667 WO2016109423A1 (en) | 2014-12-30 | 2015-12-28 | Methods for tagging dna-encoded libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201791312A1 true EA201791312A1 (ru) | 2017-10-31 |
Family
ID=56284965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201791312A EA201791312A1 (ru) | 2014-12-30 | 2015-12-28 | Способы мечения библиотек, кодируемых днк |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20180002688A1 (enExample) |
| EP (1) | EP3240795A4 (enExample) |
| JP (1) | JP6864621B2 (enExample) |
| KR (1) | KR20170094445A (enExample) |
| CN (1) | CN107428795B (enExample) |
| AU (2) | AU2015374309B2 (enExample) |
| BR (1) | BR112017013904A2 (enExample) |
| CA (1) | CA2972275A1 (enExample) |
| EA (1) | EA201791312A1 (enExample) |
| HK (1) | HK1246301A1 (enExample) |
| IL (2) | IL253154B (enExample) |
| MA (1) | MA41298A (enExample) |
| MX (1) | MX2017008772A (enExample) |
| SG (1) | SG11201705350XA (enExample) |
| WO (1) | WO2016109423A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017218293A1 (en) | 2016-06-16 | 2017-12-21 | Richard Edward Watts | Oligonucleotide directed and recorded combinatorial synthesis of encoded probe molecules |
| WO2018195134A1 (en) * | 2017-04-18 | 2018-10-25 | X-Chem, Inc. | Methods for identifying compounds |
| WO2018204420A1 (en) | 2017-05-02 | 2018-11-08 | Haystack Sciences Corporation | Molecules for verifying oligonucleotide directed combinatorial synthesis and methods of making and using the same |
| US11384376B2 (en) * | 2018-05-31 | 2022-07-12 | Roche Molecular Systems, Inc. | Reagents and methods for post-synthetic modification of nucleic acids |
| CN110658163A (zh) * | 2018-06-29 | 2020-01-07 | 成都先导药物开发股份有限公司 | 一种合成dna编码化合物中的反应监测方法 |
| CN109468310B (zh) * | 2018-10-25 | 2020-12-01 | 深圳劲宇生物科技有限公司 | Dna编码碎片分子库的合成方法和连接基团的筛选方法 |
| JP7646212B2 (ja) * | 2019-03-14 | 2025-03-17 | ヘイスタック サイエンシーズ コーポレイション | オリゴヌクレオチドコード化分子を加工または分析する方法および系 |
| WO2021115319A1 (zh) * | 2019-12-10 | 2021-06-17 | 成都先导药物开发股份有限公司 | 同时结合多个生物靶标的dna编码化合物库筛选方法 |
| EP4240863A4 (en) * | 2020-11-06 | 2025-03-12 | The University of Chicago | HAIRPIN OLIGONUCLEOTIDES AND THEIR USES |
| WO2025053257A1 (ja) * | 2023-09-07 | 2025-03-13 | 旭化成ファーマ株式会社 | オリゴヌクレオチドによりコード化された化合物の製造方法、およびその応用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038726A1 (en) * | 1995-05-30 | 1996-12-05 | Ecole Polytechnique Federale De Lausanne (Epfl) | Covalently immobilized phospholipid bilayers on solid surfaces |
| CN106337046B (zh) * | 2002-10-30 | 2021-03-23 | 纽韦卢森公司 | 合成双功能复合物的方法 |
| JP5646127B2 (ja) * | 2003-12-17 | 2014-12-24 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | コードされたライブラリーの合成のための方法 |
| US8846883B2 (en) * | 2011-08-16 | 2014-09-30 | University Of Southhampton | Oligonucleotide ligation |
| SG10201605812YA (en) * | 2011-09-07 | 2016-09-29 | Chem Inc X | Methods for tagging dna-encoded libraries |
| KR102146721B1 (ko) * | 2012-07-13 | 2020-08-21 | 엑스-켐, 인크. | 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리 |
-
2015
- 2015-12-27 MA MA041298A patent/MA41298A/fr unknown
- 2015-12-28 JP JP2017534592A patent/JP6864621B2/ja not_active Expired - Fee Related
- 2015-12-28 HK HK18105560.9A patent/HK1246301A1/zh unknown
- 2015-12-28 MX MX2017008772A patent/MX2017008772A/es unknown
- 2015-12-28 US US15/540,284 patent/US20180002688A1/en not_active Abandoned
- 2015-12-28 AU AU2015374309A patent/AU2015374309B2/en not_active Ceased
- 2015-12-28 EA EA201791312A patent/EA201791312A1/ru unknown
- 2015-12-28 CN CN201580077171.7A patent/CN107428795B/zh not_active Expired - Fee Related
- 2015-12-28 SG SG11201705350XA patent/SG11201705350XA/en unknown
- 2015-12-28 EP EP15876097.5A patent/EP3240795A4/en not_active Withdrawn
- 2015-12-28 WO PCT/US2015/067667 patent/WO2016109423A1/en not_active Ceased
- 2015-12-28 CA CA2972275A patent/CA2972275A1/en active Pending
- 2015-12-28 KR KR1020177019616A patent/KR20170094445A/ko not_active Withdrawn
- 2015-12-28 BR BR112017013904-9A patent/BR112017013904A2/pt active Search and Examination
-
2017
- 2017-06-25 IL IL253154A patent/IL253154B/en active IP Right Grant
-
2020
- 2020-09-11 AU AU2020230345A patent/AU2020230345A1/en not_active Withdrawn
- 2020-10-18 IL IL278117A patent/IL278117A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3240795A1 (en) | 2017-11-08 |
| IL278117A (en) | 2020-11-30 |
| JP6864621B2 (ja) | 2021-04-28 |
| AU2015374309A1 (en) | 2017-07-27 |
| JP2018501796A (ja) | 2018-01-25 |
| CA2972275A1 (en) | 2016-07-07 |
| AU2015374309B2 (en) | 2020-06-11 |
| AU2020230345A1 (en) | 2020-10-01 |
| HK1246301A1 (zh) | 2018-09-07 |
| IL253154A0 (en) | 2017-08-31 |
| CN107428795B (zh) | 2021-06-18 |
| EP3240795A4 (en) | 2019-02-13 |
| MX2017008772A (es) | 2018-03-15 |
| US20180002688A1 (en) | 2018-01-04 |
| BR112017013904A2 (pt) | 2018-01-02 |
| SG11201705350XA (en) | 2017-08-30 |
| MA41298A (fr) | 2017-11-07 |
| KR20170094445A (ko) | 2017-08-17 |
| WO2016109423A1 (en) | 2016-07-07 |
| IL253154B (en) | 2020-10-29 |
| CN107428795A (zh) | 2017-12-01 |
| WO2016109423A8 (en) | 2017-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791312A1 (ru) | Способы мечения библиотек, кодируемых днк | |
| EA201891093A1 (ru) | Антитела, специфически связывающие pd-1, и их применение | |
| EA201491996A1 (ru) | Антагонисты st2l и способы их применения | |
| PH12019501357A1 (en) | Anti-ox40 antibodies and their uses | |
| EA201890630A1 (ru) | Антитела против pd-1 и способы их применения | |
| SG10201911917WA (en) | Macromolecule analysis employing nucleic acid encoding | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| EA202092435A3 (ru) | Моноклональные антитела против bcma | |
| LT3594238T (lt) | Antikūno kompozicijos, skirtos navikų gydymui | |
| EA201792414A1 (ru) | Антитела против cd166, активируемые антитела против cd166 и способы их применения | |
| MX375524B (es) | Anticuerpos anti-axl. | |
| EA201791485A1 (ru) | Анти-cd47-антитела и их применения | |
| EP3180352A4 (en) | Advanced macromolecule transduction domain (amtd) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of amtds comprising the same, method to develop the amtd sequences comprising the same | |
| EA201891251A1 (ru) | Бициклические ингибиторы pad4 | |
| EA201492101A1 (ru) | Антитела против fcrn | |
| EA201790505A1 (ru) | Соединение, нацеленое на ил-23а и фно-альфа, и его применение | |
| EA201792080A1 (ru) | Гуманизированные анти-c1s антитела и способы их применения | |
| EA201890434A1 (ru) | Антитела к cd154 и способы их применения | |
| CY1124445T1 (el) | Αντισωματα αντι-ccl17 | |
| MX2017007381A (es) | Miembros de union para homologo del oncogen de fibrosarcoma musculoadoneurotico (c-maf) humano. | |
| TN2015000414A1 (en) | Proteins specific for baff and b7rp1 and uses thereof | |
| SG10201806454RA (en) | Anti-tenascin c antibodies and uses thereof | |
| EP3498275C0 (en) | USE OF COMPOUNDS KNOWN AS D-AMINOACID OXIDASE INHIBITORS | |
| MX2024000004A (es) | Proteinas de fusion de inhibidor de tripsina urinaria (uti). | |
| SI3325453T1 (sl) | Postopki kemijske sinteze substituiranih 10H-fenotiazin-3,7-diaminskih spojin |